Liver-support supplements: what works and what's just expensive urine

The liver-support supplement category is messier than most. Healthy livers in healthy adults don’t actually need supplementation — the underlying organ is remarkably resilient. But for specific situations (early fatty liver disease, heavy medication burden, alcohol use, chemical exposures), some supplements have legitimate research behind them.

The challenge is that the evidence tiers in this category are extreme. A handful of compounds have meaningful human trials at clinically relevant doses. The rest are mechanistically plausible at best and pure marketing at worst.

Here’s the honest breakdown.

Tier 1: meaningful human evidence

These are the compounds with controlled human trials, clinically relevant doses, and measurable outcomes (typically liver enzyme normalization or imaging-confirmed improvement in fatty liver).

Milk thistle (silymarin)

The most-studied liver supplement, by a wide margin. The active compound complex (silymarin/silibinin) protects hepatocytes from oxidative damage, supports regeneration, and modulates phase II detoxification enzymes [^1].

Best-supported uses:

• Adjunct in chronic hepatitis (B and C) for liver enzyme normalization
• Toxin-induced liver injury (notably amatoxin from Amanita mushroom poisoning — used in emergency medicine)
• Non-alcoholic fatty liver disease (NAFLD) — modest but measurable benefit in some trials

Clinically meaningful dose: 140-420 mg silymarin daily, divided across 2-3 doses. Most consumer “detox” products contain a dust-level amount of milk thistle. Standalone standardized milk thistle (look for 80% silymarin standardization) at appropriate dose typically costs $15-25/month.

TUDCA (tauroursodeoxycholic acid)

Less famous, increasingly studied. A bile acid derivative that reduces endoplasmic reticulum stress in liver cells and supports bile flow [^2]. Used clinically (as ursodeoxycholic acid / UDCA) for primary biliary cholangitis.

Best-supported uses:

• Bile-flow support in cholestatic conditions (clinical contexts, not OTC)
• Fatty liver / NAFLD — emerging evidence, smaller trials
• Recovery support after liver-stressing medications

Clinically meaningful dose: 250-500 mg twice daily. TUDCA is one of the more expensive evidenced supplements; expect $30-60/month for a quality product.

N-acetylcysteine (NAC)

A precursor to glutathione — the body’s primary intracellular antioxidant, heavily concentrated in the liver. NAC is used in emergency medicine as the antidote for acetaminophen overdose, and has reasonable evidence for general liver support [^4].

Best-supported uses:

• Acetaminophen toxicity (clinical use)
• Non-alcoholic fatty liver disease — modest benefit in trials
• Heavy alcohol use periods (mechanism: replenishes depleted glutathione)
• Air pollution and chemical exposure recovery

Clinically meaningful dose: 600-1200 mg daily, typically divided. NAC was briefly the subject of FDA enforcement uncertainty in 2020-2022 but is widely available again. Costs $10-20/month.

Artichoke leaf extract (cynarin)

The least famous of the four but with surprisingly good NAFLD data. Cynarin, the active compound, supports bile flow and has shown improvement in liver enzymes and ultrasound findings in fatty liver trials [^5].

Best-supported uses:

• Mild NAFLD — modest improvement in liver enzymes
• Digestive support (the bile-flow effect aids fat digestion)
• Combined with milk thistle, additive evidence for liver-enzyme outcomes

Clinically meaningful dose: 600 mg standardized extract daily. Costs $10-20/month.

Tier 2: mechanistically plausible, human evidence limited

These compounds have decent in vitro and animal data, plus some small human trials, but not enough yet to call them established:

• Curcumin (turmeric) — Strong anti-inflammatory data; liver-specific evidence is moderate. Bioavailability problem unless paired with piperine or in liposomal form.
• Resveratrol — In vitro liver-protective effects; human trials are mixed at typical supplement doses.
• Vitamin E — Has positive NAFLD trial data (PIVENS trial) at 800 IU daily, but long-term cardiovascular safety at that dose is debated [^3].
• Choline — Genuinely required for liver health; deficiency causes fatty liver. Most adults are mildly inadequate. Egg yolks are the best food source.

These are not unreasonable additions for specific situations, but they’re second-tier in evidence.

Tier 3: mostly marketing

The compounds you’ll find on consumer “liver detox” labels that have weak or no human evidence at consumer doses:

• Beetroot (cardiovascular research, not liver)
• Glutathione (orally absorbed poorly — better evidence for liposomal at much higher cost)
• Ginger (digestive support, not liver-specific)
• Schisandra berry (small trials, inconsistent results)
• Burdock root (traditional use, no rigorous trials)
• Most proprietary blends with 12+ ingredients listed in microgram quantities

This is not a moral judgment — these compounds aren’t harmful. They’re just sold beyond what the evidence supports.

The smart purchasing approach

If you have a specific situation that calls for liver support (NAFLD, medication burden, recovery period), the evidence-aligned approach is:

1. Start with the foundational interventions — reducing alcohol, addressing weight if fatty liver is the concern, controlling glucose. These move the needle more than any supplement.
2. If supplementing, buy standardized standalone products of the Tier 1 compounds — not multi-ingredient “liver complex” blends. You’ll pay less and get clinically meaningful doses.
3. Discuss with your clinician if you’re on prescription medications. Several Tier 1 compounds affect liver enzymes that metabolize drugs.

A reasonable stack for someone with mild NAFLD (with clinician input): 280 mg silymarin daily + 600 mg NAC daily + 600 mg artichoke. Total cost: roughly $40-60/month. The equivalent in a branded “liver detox” multi-blend often costs more and delivers less.

When NOT to supplement

A few situations where liver supplements are inappropriate or risky:

• Active liver disease without clinician supervision. Some supplements interact with treatment.
• Pregnancy. Most liver supplements aren’t adequately tested.
• Hepatitis treatment regimens. Possible interactions with antiviral drugs.
• Polypharmacy. Each added supplement adds interaction risk.